LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 93 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $972,495 | -53.6% | 661,561 | +0.4% | 0.00% | – |
| Q2 2023 | $2,096,234 | +35.8% | 659,193 | +0.8% | 0.00% | – |
| Q1 2023 | $1,543,298 | -32.2% | 653,940 | -0.3% | 0.00% | -100.0% |
| Q4 2022 | $2,277,049 | -52.8% | 656,210 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $4,829,000 | +34.9% | 658,756 | +19.9% | 0.00% | 0.0% |
| Q2 2022 | $3,581,000 | +81.8% | 549,261 | +40.8% | 0.00% | – |
| Q1 2022 | $1,970,000 | +256.9% | 390,166 | +447.4% | 0.00% | – |
| Q4 2021 | $552,000 | -36.3% | 71,276 | +21.6% | 0.00% | – |
| Q3 2021 | $867,000 | – | 58,618 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $29,638,628 | 28.72% |
| Orland Properties Ltd | 15,093,969 | $22,188,134 | 11.75% |
| Foresite Capital Management IV, LLC | 8,784,813 | $12,913,675 | 7.17% |
| MIC Capital Management UK LLP | 1,740,569 | $2,558,636 | 0.58% |
| Alphabet Inc. | 5,865,125 | $8,621,733 | 0.55% |
| HSG Holding Ltd | 3,045,997 | $4,477,616 | 0.48% |
| Clarius Group, LLC | 399,168 | $586,777 | 0.06% |
| CAXTON ASSOCIATES LP | 198,477 | $291,761 | 0.04% |
| XTX Topco Ltd | 114,720 | $168,638 | 0.03% |
| BBR PARTNERS, LLC | 164,041 | $241,140 | 0.03% |